Pure Autonomic Failure (PAF), also known as Chronic Autonomic Failure or Idiopathic Orthostatic Hypotension, is a rare neurodegenerative disorder characterized by progressive failure of the autonomic nervous system[1]. Unlike multiple system atrophy (MSA), which involves both autonomic dysfunction and motor symptoms, PAF presents primarily with autonomic impairment without significant motor deficits in its early stages[2]. The condition is associated with degeneration of postganglionic autonomic neurons and often involves alpha-synuclein pathology, linking it to the broader spectrum of synucleinopathies[3].
Pure Autonomic Failure is a rare disorder with an estimated prevalence of 9-18 per million population[4]. The condition typically presents in middle age (40-60 years) but can occur at any age. There is no clear gender predominance. Most cases appear to be sporadic, though familial cases have been reported, suggesting potential genetic factors in some individuals[5].
The majority of Pure Autonomic Failure cases are sporadic with no clear inheritance pattern. However, research has identified several genetic associations:
Unlike familial dysautonomia (Riley-Day syndrome), which has a known genetic basis (IKBKAP gene), PAF remains largely idiopathic. The condition is considered a sporadic synucleinopathy rather than a primarily genetic disorder[9].
Pure Autonomic Failure is classified as a synucleinopathy, sharing pathological features with Parkinson's disease, Dementia with Lewy Bodies, and multiple system atrophy[10]. The key pathological features include:
The primary pathophysiology involves impaired sympathetic vasomotor control:
Autonomic failure in PAF selectively affects:
| Symptom | Description |
|---|---|
| Orthostatic hypotension | Fall in systolic BP ≥20 mm Hg or diastolic ≥10 mm Hg within 3 minutes of standing |
| Postprandial hypotension | Worsening of hypotension after meals due to splanchnic vasodilation |
| Supine hypertension | Paradoxical high blood pressure when lying down |
| Reflex tachycardia | Inadequate or absent compensatory heart rate increase |
Diagnosis is based on the presence of:
| Test | Purpose |
|---|---|
| Tilt table test | Confirms orthostatic hypotension, documents BP/HR response |
| Plasma catecholamines | Low norepinephrine in supine position, inadequate rise on standing |
| Thermoregulatory sweat test | Documents pattern of anhidrosis |
| Heart rate variability | Assesses cardiovagal function |
| MRI brain | Rules out structural causes, looks for MSA signs |
| DAT scan | May show preserved dopamine transporters (distinguishes from PD)[15] |
| Condition | Distinguishing Features |
|---|---|
| Multiple System Atrophy | Parkinsonism, cerebellar signs, earlier urinary incontinence |
| Parkinson's Disease | Resting tremor, bradykinesia, Lewy body pathology |
| Diabetic autonomic neuropathy | Known diabetes history, length-dependent neuropathy |
| Drug-induced orthostasis | Clear temporal relationship to medication |
| Volume depletion | Resolves with fluid replacement[16] |
| Medication | Mechanism | Dose |
|---|---|---|
| Fludrocortisone | Mineralocorticoid, expands volume | 0.05-0.3 mg/day |
| Midodrine | Alpha-1 agonist, vasoconstriction | 2.5-10 mg TID |
| Pyridostigmine | Acetylcholinesterase, enhances ganglionic transmission | 30-60 mg TID |
| Droxidopa | Norepinephrine prodrug | 100-600 mg TID |
| Atomoxetine | Norepinephrine reuptake inhibitor | 10-18 mg BID |
| Ivabradine | If inappropriate tachycardia | 2.5-7.5 mg BID[18] |
Pure Autonomic Failure is typically progressive, with gradual worsening of autonomic symptoms over years. The rate of progression varies significantly between individuals. Unlike MSA, which progresses rapidly (median survival 6-10 years), PAF has a more indolent course[20].
PAF exists on a spectrum with other alpha-synucleinopathies:
Autonomic dysfunction, particularly reduced noradrenergic innervation measured by cardiac MIBG scintigraphy or PET imaging, may serve as an early biomarker for synucleinopathies[22].
Current research focuses on:
Recent research on Pure Autonomic Failure includes: